FDA Adverse Event Injury Summary report: N

ISPAN PERFLUOROPROPANE (C3F8 GAS)

MDR report key: 23451304 · Received November 3, 2025

Report

Report Number
0002518435-2025-00051
Event Type
Injury
Date Received
November 3, 2025
Date of Event
August 29, 2025
Report Date
December 24, 2025
Manufacturer
AIRGAS THERAPEUTICS LLC
Product Code
LPO
UDI-DI
00380657971039
PMA / PMN Number
P900066
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

NO SAMPLE WAS RETURNED FOR EVALUATION. ANALYSIS OF THE RETAIN SAMPLE FROM THE SAME MASTER LOT AS LOT 406501 AND 406405 CONFIRMED THE PRODUCT AS C3F8 AND MEETS ALL RELEASE CRITERIA.

Additional Manufacturer Narrative · 0

NO SAMPLE WAS RETURNED FOR EVALUATION. ANALYSIS OF THE RETAIN SAMPLE FROM THE SAME MASTER LOT AS LOT 406501 CONFIRMED THE PRODUCT AS C3F8 AND MEETS ALL RELEASE CRITERIA.

Description of Event or Problem · 0

(B)(6)_CLINICAL TRIAL STUDY. A HEALTHCARE PROFESSIONAL REPORTED THAT A PATIENT EXPERIENCED MILD POSTOPERATIVE HIGH INTRAOCULAR PRESSURE IN THE RIGHT EYE FOLLOWING VITRECTOMY+VITREOUS PUNCTURE INJECTION + INTERNAL OPHTHALMOPATHY CONDENSATION + COMPLEX RETINAL DETACHMENT INTERNAL PRESSURE REPAIR SURGERY. DRUG THERAPY GIVEN, PATIENT RECOVERED. UPDATE: LOT UPDATED BY ALCON ON DECEMBER 24, 2025, FROM 406501 TO 406405. THESE LOTS ARE FROM THE SAME MASTER LOT OF C3F8.

Description of Event or Problem · 0

(B)(6) CLINICAL TRIAL STUDY A HEALTHCARE PROFESSIONAL REPORTED THAT A PATIENT EXPERIENCED MILD POSTOPERATIVE HIGH INTRAOCULAR PRESSURE IN THE RIGHT EYE FOLLOWING VITRECTOMY+VITREOUS PUNCTURE INJECTION + INTERNAL OPHTHALMOPATHY CONDENSATION + COMPLEX RETINAL DETACHMENT INTERNAL PRESSURE REPAIR SURGERY DRUG THERAPY GIVEN, PATIENT RECOVERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1558846 ISPAN PERFLUOROPROPANE (C3F8 GAS) INTRAOCULAR GAS LPO AIRGAS THERAPEUTICS LLC 406405 00380657971039

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other